[Effects of insulin and acidosis on metabolism and function of postischemic rat heart]. 2009

O I Pisarenko, and V S Shul'zhenko, and I M Studneva

Isolated perfused hearts of male Wistar rats were subjected to 25-min normothermic (37 degrees C) global ischemia, then 5-min infusion of a modified perfusate (pH=7.4) and 25-min reperfusion (control). Experimental groups were treated after ischemia with: a perfusate of the same composition (pH=6.0, RA), a perfusate, containing insulin 2 U/l (pH=7.4, RI) or a perfusate with insulin 2 U/l (pH=6.0, RIA). In the RA, RI and RIA groups a 2-4 folds reduction of contracture was combined with an augmented recovery of the aortic outflow, the cardiac and stroke volumes, compared with these indices in the control during reperfusion. At the end of the reperfusion an improved ATP and phosphocreatine (PCr) recovery in the RA and RI groups was accompanied by reduction of intracellular total creatine (SigmaCr = PCr + creatine) compared with corresponding values in control. Lactate content of reperfused hearts in the RA group was 2.3-times lower than in the control one, but it was almost twice higher in the RI group because of glycolysis stimulation. The most effective recovery of high energy phosphates in the RI group corresponded to reduction of glutamate and aspartate catabolism--total myocardial pool of these amino acids was 1.5-times higher than in the control, and individual amino acid contents did not differ significantly from initial values. Infusion of the acidified perfusate with insulin (the RIA group) resulted in neither improvement of high energy phosphate recovery nor preservation of myocardial amino acid and SigmaCr pools, compared with these indices in control. The lack of augmented metabolic effects of combined treatment with acidosis and insulin in the RIA group was accompanied by nearly the same recovery of majority of functional indices as was observed in RA and RI groups. The absence of additive protective effects of insulin and acidosis on early reperfusion was probably induced by acidosis induced inhibition of insulin-stimulated glucose uptake and glycolysis.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

O I Pisarenko, and V S Shul'zhenko, and I M Studneva
March 1990, The American journal of physiology,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
September 1992, The American journal of physiology,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
May 2003, Molecular and cellular biochemistry,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
January 1952, Diabetes,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
January 1973, The American journal of physiology,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
July 1978, The American journal of physiology,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
August 1998, The Journal of pharmacology and experimental therapeutics,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
March 2000, Molecular and cellular biochemistry,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
April 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
O I Pisarenko, and V S Shul'zhenko, and I M Studneva
June 1988, Biochemical pharmacology,
Copied contents to your clipboard!